These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7010363)

  • 21. Ovarian hormones inhibit the release of prostacyclin-like material from isolated rat uterus.
    Gimeno MF; Borda ES; Lazzari MA; Gimeno AL
    Prostaglandins; 1980 Aug; 20(2):223-32. PubMed ID: 6997929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dilazep on human platelets and rat vascular tissue: in vitro studies on platelet aggregation, and arachidonic acid oxidation.
    Colli S; Maderna P; Morazzoni G; Speroni C; Tremoli E
    Pharmacol Res Commun; 1983 Jun; 15(6):593-602. PubMed ID: 6412253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac prostacyclin release: stimulation by hypoxia and various agents.
    Kirstein A
    Scand J Haematol Suppl; 1979; 34():105-11. PubMed ID: 384504
    [No Abstract]   [Full Text] [Related]  

  • 24. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Nature; 1978 Jun; 273(5665):765-7. PubMed ID: 351417
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostacyclin content of gastric and duodenal biopsies.
    Rózsa I; Banai J; Tihanyi K; Rákóczi I; Kun M
    Gastroenterol Jpn; 1982; 17(1):1-3. PubMed ID: 7042448
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of heparin on prostacyclin activity of the aorta wall].
    Baluda VP; Sushkevich GN; Liasko LI
    Biull Eksp Biol Med; 1982 Sep; 94(9):79-80. PubMed ID: 6756506
    [No Abstract]   [Full Text] [Related]  

  • 27. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostacyclin activity in rat kidney stimulated by angiotensin II.
    Silberbauer K; Sinzinger H; Winter M
    Br J Exp Pathol; 1979 Feb; 60(1):38-44. PubMed ID: 380621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanism of angiotensin II induced release of prostacyclin.
    Swies J; Radomski M; Gryglewski RJ
    Pharmacol Res Commun; 1981 Jan; 13(1):37-40. PubMed ID: 7012845
    [No Abstract]   [Full Text] [Related]  

  • 30. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.
    Merino J; Livio M; Rajtar G; de Gaetano G
    Biochem Pharmacol; 1980 Apr; 29(8):1093-6. PubMed ID: 6770871
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats.
    Shibouta Y; Inada Y; Terashita Z; Nishikawa K; Kikuchi S; Shimamoto K
    Biochem Pharmacol; 1979 Dec; 28(24):3601-9. PubMed ID: 394747
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology and therapeutic potential of prostacyclin.
    Moncada S
    Stroke; 1983; 14(2):157-68. PubMed ID: 6301111
    [No Abstract]   [Full Text] [Related]  

  • 34. Modified sensitivity of diabetic platelets to prostacyclin.
    Bonne C; Romquin N; Regnault F
    Bibl Anat; 1979; (18):98-103. PubMed ID: 227357
    [No Abstract]   [Full Text] [Related]  

  • 35. 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.
    Quilley CP; McGiff JC; Lee WH; Sun FF; Wong PY
    Hypertension; 1980; 2(4):524-8. PubMed ID: 6995292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C; Winter M; Silbauer K; Wagner O; Pinggera W; Sinzinger H
    Proc Eur Dial Transplant Assoc; 1978; 15():418-23. PubMed ID: 368786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose aspirin (ASA) renders human platelets more vulnerable to inhibition of aggregation by prostacyclin (PGI2).
    Philp RB; Paul ML
    Prostaglandins Leukot Med; 1983 Jun; 11(2):131-42. PubMed ID: 6348804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Almitrine increases plasma fibrinolytic activity through the release of prostacyclin from lungs into circulation.
    Korbut R; Byrska-Danek A; Gryglewski RJ
    Pharmacol Res Commun; 1982 Nov; 14(10):959-65. PubMed ID: 6760210
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostaglandins, platelets, and atherosclerosis.
    Gryglewski RJ
    CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.